
### [NCIT:C3729](http://purl.obolibrary.org/obo/NCIT_C3729)
**Label:** Malignant Mixed Neoplasm

**Subclasses:** [NCIT:C3267](http://purl.obolibrary.org/obo/NCIT_C3267) (Wilms Tumor), [NCIT:C27730](http://purl.obolibrary.org/obo/NCIT_C27730) (Childhood Kidney Wilms Tumor), [NCIT:C6336](http://purl.obolibrary.org/obo/NCIT_C6336) (Uterine Corpus Adenosarcoma), [NCIT:C6897](http://purl.obolibrary.org/obo/NCIT_C6897) (Cystic Partially Differentiated Nephroblastoma), [NCIT:C7267](http://purl.obolibrary.org/obo/NCIT_C7267) (Combined Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C4275](http://purl.obolibrary.org/obo/NCIT_C4275) (Malignant Phyllodes Tumor), [NCIT:C4397](http://purl.obolibrary.org/obo/NCIT_C4397) (Carcinoma ex Pleomorphic Adenoma), [NCIT:C40229](http://purl.obolibrary.org/obo/NCIT_C40229) (Cervical Adenosarcoma), [NCIT:C40228](http://purl.obolibrary.org/obo/NCIT_C40228) (Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C4195](http://purl.obolibrary.org/obo/NCIT_C4195) (Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ), [NCIT:C40347](http://purl.obolibrary.org/obo/NCIT_C40347) (Invasive Mixed Breast Carcinoma), [NCIT:C6180](http://purl.obolibrary.org/obo/NCIT_C6180) (Adult Kidney Wilms Tumor), [NCIT:C7591](http://purl.obolibrary.org/obo/NCIT_C7591) (Combined Lung Carcinoma), [NCIT:C35831](http://purl.obolibrary.org/obo/NCIT_C35831) (Carcinosarcoma of the Salivary Gland), [NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma), [NCIT:C35832](http://purl.obolibrary.org/obo/NCIT_C35832) (Parotid Gland Carcinosarcoma), [NCIT:C6939](http://purl.obolibrary.org/obo/NCIT_C6939) (Ductal Breast Carcinoma In Situ and Invasive Lobular Carcinoma), [NCIT:C5976](http://purl.obolibrary.org/obo/NCIT_C5976) (Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C5977](http://purl.obolibrary.org/obo/NCIT_C5977) (Submandibular Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C5974](http://purl.obolibrary.org/obo/NCIT_C5974) (Parotid Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C7317](http://purl.obolibrary.org/obo/NCIT_C7317) (Ovarian Adenosarcoma), [NCIT:C5975](http://purl.obolibrary.org/obo/NCIT_C5975) (Major Salivary Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C5531](http://purl.obolibrary.org/obo/NCIT_C5531) (Malignant Prostate Phyllodes Tumor), [NCIT:C40410](http://purl.obolibrary.org/obo/NCIT_C40410) (Salivary Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C9180](http://purl.obolibrary.org/obo/NCIT_C9180) (Uterine Corpus Carcinosarcoma), [NCIT:C96888](http://purl.obolibrary.org/obo/NCIT_C96888) (Gallbladder Carcinosarcoma), [NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma), [NCIT:C96848](http://purl.obolibrary.org/obo/NCIT_C96848) (Liver Carcinosarcoma), [NCIT:C113239](http://purl.obolibrary.org/obo/NCIT_C113239) (Uterine Carcinosarcoma, Heterologous Type), [NCIT:C67092](http://purl.obolibrary.org/obo/NCIT_C67092) (Ovarian Serous Adenocarcinofibroma), [NCIT:C5944](http://purl.obolibrary.org/obo/NCIT_C5944) (Malignant Submandibular Gland Mixed Tumor), [NCIT:C5945](http://purl.obolibrary.org/obo/NCIT_C5945) (Malignant Parotid Gland Mixed Tumor), [NCIT:C113238](http://purl.obolibrary.org/obo/NCIT_C113238) (Uterine Carcinosarcoma, Homologous Type), [NCIT:C5902](http://purl.obolibrary.org/obo/NCIT_C5902) (Malignant Mixed Tumor of the Major Salivary Gland), [NCIT:C7843](http://purl.obolibrary.org/obo/NCIT_C7843) (Stage IV Kidney Wilms Tumor), [NCIT:C7689](http://purl.obolibrary.org/obo/NCIT_C7689) (Invasive Ductal and Lobular Carcinoma In Situ), [NCIT:C6952](http://purl.obolibrary.org/obo/NCIT_C6952) (Anaplastic Kidney Wilms Tumor), [NCIT:C7688](http://purl.obolibrary.org/obo/NCIT_C7688) (Invasive Ductal and Lobular Carcinoma), [NCIT:C7842](http://purl.obolibrary.org/obo/NCIT_C7842) (Stage III Kidney Wilms Tumor), [NCIT:C6951](http://purl.obolibrary.org/obo/NCIT_C6951) (Nonanaplastic Kidney Wilms Tumor), [NCIT:C8975](http://purl.obolibrary.org/obo/NCIT_C8975) (Malignant Mixed Mesodermal (Mullerian) Tumor), [NCIT:C7845](http://purl.obolibrary.org/obo/NCIT_C7845) (Recurrent Kidney Wilms Tumor), [NCIT:C9149](http://purl.obolibrary.org/obo/NCIT_C9149) (Mixed Cell Type Kidney Wilms Tumor), [NCIT:C40407](http://purl.obolibrary.org/obo/NCIT_C40407) (Kidney Wilms Tumor), [NCIT:C7685](http://purl.obolibrary.org/obo/NCIT_C7685) (Adenocarcinoma with Cartilaginous Metaplasia), [NCIT:C7684](http://purl.obolibrary.org/obo/NCIT_C7684) (Adenocarcinoma with Osseous Metaplasia), [NCIT:C9147](http://purl.obolibrary.org/obo/NCIT_C9147) (Blastema Predominant Kidney Wilms Tumor), [NCIT:C7841](http://purl.obolibrary.org/obo/NCIT_C7841) (Stage II Kidney Wilms Tumor), [NCIT:C9148](http://purl.obolibrary.org/obo/NCIT_C9148) (Stromal Predominant Kidney Wilms Tumor), [NCIT:C6311](http://purl.obolibrary.org/obo/NCIT_C6311) (Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C45543](http://purl.obolibrary.org/obo/NCIT_C45543) (Lung Carcinosarcoma), [NCIT:C7840](http://purl.obolibrary.org/obo/NCIT_C7840) (Stage I Kidney Wilms Tumor), [NCIT:C8496](http://purl.obolibrary.org/obo/NCIT_C8496) (Hereditary Wilms Tumor), [NCIT:C6393](http://purl.obolibrary.org/obo/NCIT_C6393) (Invasive Ductal and Invasive Lobular Breast Carcinoma), [NCIT:C9146](http://purl.obolibrary.org/obo/NCIT_C9146) (Epithelial Predominant Kidney Wilms Tumor), [NCIT:C7683](http://purl.obolibrary.org/obo/NCIT_C7683) (Adenocarcinoma with Cartilaginous and Osseous Metaplasia), [NCIT:C42700](http://purl.obolibrary.org/obo/NCIT_C42700) (Uterine Carcinosarcoma), [NCIT:C40443](http://purl.obolibrary.org/obo/NCIT_C40443) (Ovarian Wilms Tumor), [NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma), [NCIT:C96939](http://purl.obolibrary.org/obo/NCIT_C96939) (Extrahepatic Bile Duct Carcinosarcoma), [NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma), [NCIT:C7690](http://purl.obolibrary.org/obo/NCIT_C7690) (Intraductal and Lobular Carcinoma), [NCIT:C9192](http://purl.obolibrary.org/obo/NCIT_C9192) (Ovarian Carcinosarcoma), [NCIT:C102570](http://purl.obolibrary.org/obo/NCIT_C102570) (Uterine Ligament Adenosarcoma), [NCIT:C128165](http://purl.obolibrary.org/obo/NCIT_C128165) (Malignant Vulvar Phyllodes Tumor), [NCIT:C34448](http://purl.obolibrary.org/obo/NCIT_C34448) (Carcinosarcoma), [NCIT:C5955](http://purl.obolibrary.org/obo/NCIT_C5955) (Malignant Mixed Tumor of the Minor Salivary Gland), [NCIT:C4504](http://purl.obolibrary.org/obo/NCIT_C4504) (Malignant Breast Phyllodes Tumor), [NCIT:C6804](http://purl.obolibrary.org/obo/NCIT_C6804) (Lacrimal Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C8025](http://purl.obolibrary.org/obo/NCIT_C8025) (Malignant Mixed Tumor of the Salivary Gland), [NCIT:C40236](http://purl.obolibrary.org/obo/NCIT_C40236) (Cervical Wilms Tumor), [NCIT:C9474](http://purl.obolibrary.org/obo/NCIT_C9474) (Adenosarcoma), [NCIT:C37265](http://purl.obolibrary.org/obo/NCIT_C37265) (Malignant Mixed Epithelial Stromal Tumor of the Kidney), [NCIT:C36097](http://purl.obolibrary.org/obo/NCIT_C36097) (Cervical Carcinosarcoma), [NCIT:C38158](http://purl.obolibrary.org/obo/NCIT_C38158) (Metachronous Wilms Tumor), [NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C40035](http://purl.obolibrary.org/obo/NCIT_C40035) (Adenocarcinofibroma), [NCIT:C5160](http://purl.obolibrary.org/obo/NCIT_C5160) (Mixed Lobular and Ductal Breast Carcinoma), [NCIT:C121787](http://purl.obolibrary.org/obo/NCIT_C121787) (Malignant Mixed Tumor, Not Otherwise Specified), 

**Class expressions from DL-Learner:**

- Thing 51.96%
- [NCIT:C41610](http://purl.obolibrary.org/obo/NCIT_C41610) (Mixed Cellular Population) 37.20%
- [CL:0000125](http://purl.obolibrary.org/obo/CL_0000125) (glial cell) 33.33%
- [CL:0000095](http://purl.obolibrary.org/obo/CL_0000095) (neuron associated cell) 33.33%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 21.80%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 21.51%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 20.18%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 20.01%
- [CL:0002319](http://purl.obolibrary.org/obo/CL_0002319) (neural cell) 19.80%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 18.68%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 12.40%
- [CL:0000548](http://purl.obolibrary.org/obo/CL_0000548) (animal cell) 12.25%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 12.25%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 12.04%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 12.03%


